000			01957 a2200493 4500
005			20250516074619.0
264		0	_c20120325
008			201203s 0 0 eng d
022			_a1791-7530
040			_aNLM _beng _cNLM
100	1		_aSchult, Catrin
245	0	0	_aThe dual kinase inhibitor NVP-BEZ235 in combination with cytotoxic drugs exerts anti-proliferative activity towards acute lymphoblastic leukemia cells. _h[electronic resource]
260			_bAnticancer research _cFeb 2012
300			_a463-74 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xpharmacology
650	0	4	_aCell Cycle Checkpoints _xdrug effects
650	0	4	_aCell Growth Processes _xdrug effects
650	0	4	_aCell Line, Tumor
650	0	4	_aCytarabine _xadministration & dosage
650	0	4	_aDexamethasone _xadministration & dosage
650	0	4	_aDoxorubicin _xadministration & dosage
650	0	4	_aDrug Resistance, Neoplasm
650	0	4	_aDrug Synergism
650	0	4	_aHumans
650	0	4	_aImidazoles _xadministration & dosage
650	0	4	_aJurkat Cells
650	0	4	_aLeukemia, B-Cell _xdrug therapy
650	0	4	_aOncogene Protein v-akt _xantagonists & inhibitors
650	0	4	_aPhosphatidylinositol 3-Kinase _xmetabolism
650	0	4	_aPhosphoinositide-3 Kinase Inhibitors
650	0	4	_aPrecursor Cell Lymphoblastic Leukemia-Lymphoma _xdrug therapy
650	0	4	_aPrecursor T-Cell Lymphoblastic Leukemia-Lymphoma _xdrug therapy
650	0	4	_aQuinolines _xadministration & dosage
650	0	4	_aSignal Transduction
650	0	4	_aTOR Serine-Threonine Kinases _xantagonists & inhibitors
700	1		_aDahlhaus, Meike
700	1		_aGlass, Aenne
700	1		_aFischer, Kristin
700	1		_aLange, Sandra
700	1		_aFreund, Mathias
700	1		_aJunghanss, Christian
773	0		_tAnticancer research _gvol. 32 _gno. 2 _gp. 463-74
999			_c21501144 _d21501144